Viewing Study NCT02783612


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-02-28 @ 5:31 AM
Study NCT ID: NCT02783612
Status: UNKNOWN
Last Update Posted: 2016-05-26
First Post: 2016-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Digital Glucose Monitoring in Gestational Diabetes
Sponsor: Wolfson Medical Center
Organization:

Study Overview

Official Title: Improvement of Compliance by Digital Blood Glucose Monitoring of Women With Gestational Diabetes
Status: UNKNOWN
Status Verified Date: 2016-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Assessing blood glucose control in women with gestational diabetes can be challenging. The standard of care remains visual inspection of blood glucose paper diaries of self-performed capillary monitoring during regular meeting in High Risk pregnancy clinics.

The researchers are interested in preforming a randomized control trial comparing women with the diagnosis of gestational diabetes with regular High-Risk clinic surveillance to digital monitoring using an application in a Smart-phone and submitting those values via email in addition to the regular clinic appointments.

The Primary outcome of the trial is to assess the compliance of the research group as compared to the control group.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: